GPs, pharmacists and geriatricians from across the country gathered at the Royal Pharmaceutical Society in London on 23 November to celebrate five years since the launch of the Polypharmacy Action Learning Sets, an evidenced-based education approach to upskill primary care in addressing problematic or unnecessary polypharmacy in their patients.
Speakers included Professor Tony Avery, NHS England’s National Clinical Lead for Prescribing; Dr Lucy Pollock, Consultant Geriatrician at Somerset NHS Foundation Trust and author of ‘The Book About Getting Older’; David Webb, NHS England’s Chief Pharmaceutical Officer; Adam Todd, Professor of Pharmaceutical Public Health at Newcastle University; and Clare Howard, Clinical Lead for the Health Innovation Network’s national Polypharmacy programme.
The Action Learning Sets form an important part of the national Polypharmacy Programme, led by Health Innovation West of England.
The programme is supporting healthcare professionals to identify patients at potential risk from harm and facilitate better conversations about medicines.
Action Learning Sets are a structured method enabling small groups to explore complicated issues by meeting regularly and working collectively. We have used the approach to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
As of November 2023, 638 delegates across England have participated in the Polypharmacy Action Learning Sets. Our ambition is to increase this number to 1,000 by March 2024.
At the celebration event we launched our ‘state of the nation’ report, showcasing the learning from our Action Learning Sets and providing recommendations for change. The insights detailed in the report include:
- Confidence amongst GPs and pharmacists to stop medicines safely is a significant issue.
- Shared decision making with the patient is the key to solving problematic polypharmacy.
- Primary care has the data and the tools but both clinicians and patients need more support to use these effectively.
- Geriatricians see the impact of overprescribing and they are essential to help primary care tackle the issue.
- Primary care networks (PCNs) are hugely variable in the make-up and some roles under the Additional Roles Reimbursement Scheme (ARRS) need much more support.
- We need to engage our secondary care colleagues in this work going forward.
- Funding needs to be guaranteed and for a minimum of two years (ideally five) to continue successful delivery of a robust and well-resourced training offer to GPs and pharmacists.
- We need to establish a deprescribing network in England.
Download the full report here.
The event also featured posters created by Action Learning Set delegates on a wide range of quality improvement (QI) projects they have undertaken to address problematic polypharmacy in their workplace to drive and accelerate changes in practice.
Take a look at the Polypharmacy QI posters here.
Watch our short film to find out more about our Polypharmacy Action Learning Sets.
Register your interest to join a future Polypharmacy Action Learning Set here.
West of England polypharmacy community of practice
Colleagues with an interest in medicines optimisation and/or frailty and geriatrics are very welcome to join our regular regional community of practice events focused on tackling problematic polypharmacy. These events provide a platform for members to hear from nationally and locally recognised expert guest speakers, meet other colleagues in the region, share experiences, challenges and project work.
Find out more about our polypharmacy activity in the West of England or email healthinnowest.transformation@nhs.net to find out more.
Posted on November 28, 2023
News you may like
Empowering patients and upskilling clinicians to tackle overprescribing
As the Health Innovation Network’s Polypharmacy: Getting the Balance Right programme – which we have led on behalf of the Network – draws to a close, a suite of new reports highlights its transformative impact on patient safety and clinical practice across England. The programme has successfully engaged with over 12,000 healthcare professionals to support…
Read more
New resources to support Structured Medication Reviews with care home residents
The Health Innovation Network has launched a new suite of resources specifically designed to support residents, their families, and care home staff in preparing for and participating in Structured Medication Reviews (SMRs). Developed by the NIHR Yorkshire and Humber Patient Safety Research Collaboration, the resources were co-designed with care home residents, relatives and staff. These…
Read more
New insights on improving access to Structured Medication Reviews for seldom-heard communities
The Health Innovation Network has published a new report sharing insights and lessons from its initiative to improve access to Structured Medication Reviews for patients in seldom-heard communities, particularly those living in areas of high deprivation and from ethnic minority groups. The report, based on pilots delivered in 27 Primary Care Networks (PCNs) across England, demonstrates how…
Read more
